Emotional distress in patients with retinal disease

American Journal of Ophthalmology
I U ScottK Bandeen-Roche

Abstract

To investigate the prevalence of, and potential risk factors for, emotional distress among patients with retinal disease. Cross-sectional study. Cases consisted of 86 consecutive patients at Wilmer Eye Institute Retinal Vascular Center. Fifty-one controls with normal visual acuity and no known ocular disease were frequency-matched to the cases by age, sex, and race. Subjects were interviewed using the Community Disability Scale, a functional status questionnaire, and the General Health Questionnaire, a questionnaire assessing emotional distress. The prevalence of probable (General Health Questionnaire score 4 or greater and less than 10) or definite (General Health Questionnaire score 10 or greater) emotional distress was 59.3% among ophthalmic patients and 2.0% among controls. There were significant relationships between emotional distress, as assessed by General Health Questionnaire score, and degree of 1) visual impairment, as assessed by weighted bilateral average logarithm of minimal angle of resolution (logMAR), and 2) functional impairment, as assessed by Community Disability Scale score (P =.001). Univariate analyses identified significant predictors of emotional distress: shorter duration of ocular disease (P =.019), w...Continue Reading

References

Feb 1, 1979·Psychological Medicine·D P Goldberg, V F Hillier
Jun 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·R A Finlay-Jones, E Murphy
May 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·S HendersonG P Steele
Jul 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·D P GoldbergP Hesbacher
Nov 1, 1976·American Journal of Optometry and Physiological Optics·I L Bailey, J E Lovie
Feb 1, 1991·Psychological Medicine·S S Bassett, M F Folstein
Feb 1, 1970·British Journal of Preventive & Social Medicine·D P GoldbergM Shepherd
Jul 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·B SingermanM Folstein
Mar 1, 1994·Archives of Ophthalmology·I U ScottM F Folstein
Nov 21, 1997·Archives of Ophthalmology·R K ParrishA Montenegro-Piniella
Sep 11, 1999·American Journal of Ophthalmology·I U ScottC J Pappas
May 5, 2001·American Journal of Ophthalmology·I U ScottM F Folstein

❮ Previous
Next ❯

Citations

Sep 26, 2003·The British Journal of Ophthalmology·C Meads, C Hyde
Feb 22, 2005·The British Journal of Ophthalmology·H T V VuH R Taylor
Nov 1, 2008·Indian Journal of Ophthalmology·Anindya BanerjeeAmod Gupta
Jan 1, 2008·Middle East African Journal of Ophthalmology·Emad AbboudWaleed Riad
Sep 19, 2006·Biostatistics·Brian L EglestonSheila K West
May 5, 2001·American Journal of Ophthalmology·I U ScottM F Folstein
Jun 8, 2004·Clinical & Experimental Ophthalmology·Joseph Tak Fai LauJohn Michon
May 7, 2010·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Keziah Latham, Claire Usherwood
Jun 11, 2005·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·William Tasman, Barry Rovner
Jun 3, 2014·Health and Quality of Life Outcomes·Juliane LeissnerAlarcos Cieza
May 31, 2007·British Journal of Health Psychology·Laura E DreerJ Christopher McNeal
Apr 9, 2010·Current Opinion in Ophthalmology·Davin JohnsonSanjay Sharma
Apr 25, 2007·Ophthalmic Genetics·Dalbhir JangraAlex V Levin
Apr 9, 2013·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Sarah KimHyun Ki Lee
Jul 13, 2021·Frontiers in Psychology·Ami RokachAlison Rose

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.